Seniors need to examine insurance plans carefully to avoid devastating financial surprises. It's not easy, though, as insurance becomes increasingly complex with sometimes widely disparate rules for various scenarios.
When 87-year-old Lee Koff received a new defibrillator implant in January at Lourdes Medical Center in Camden, he paid estimated out-of-pocket costs of $125.
That was not much more than the $81 he paid in 2010 for his previous defibrillator, a device that regulates his heartbeat.
But about two months after the January procedure, Koff, who has Medicare Advantage health insurance from Horizon Blue Cross Blue Shield of New Jersey, received a statement saying he owed Lourdes $6,071.
"If they had said the estimate was $6,100, I would have said, 'Whoa, I have to think about that,' " Koff said.
When 87-year-old Lee Koff received a new defibrillator implant in January at Lourdes Medical Center in Camden, he paid estimated out-of-pocket costs of $125.
That was not much more than the $81 he paid in 2010 for his previous defibrillator, a device that regulates his heartbeat.
But about two months after the January procedure, Koff, who has Medicare Advantage health insurance from Horizon Blue Cross Blue Shield of New Jersey, received a statement saying he owed Lourdes $6,071.
Koff was dumbfounded. He and his daughter, Wendy Krevitz, said they had asked Lourdes office personnel if there were any other costs Koff would have to pay and were not told of any.
Read the full story here: http://bit.ly/19WhnD1
Source: Philly.com
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
More Care Doesn't Equal Happier Patients in Traditional Medicare
March 17th 2025Data on care satisfaction, ease managing care, and out-of-pocket spending were the outcomes of interest for this new analysis that investigated the relationship between healthcare utilization and beneficiary experience within traditional Medicare.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
More Care Doesn't Equal Happier Patients in Traditional Medicare
March 17th 2025Data on care satisfaction, ease managing care, and out-of-pocket spending were the outcomes of interest for this new analysis that investigated the relationship between healthcare utilization and beneficiary experience within traditional Medicare.
Read More
2 Commerce Drive
Cranbury, NJ 08512